Crohn’s Disease Market DelveInsight’s ‘Crohn’s Disease Market Insights, Epidemiology, and Market Forecast – 2030’ report delivers an in-depth un… Read More

Talicia® is indicated for the treatment of Helicobacter pylori infection in adults Patients can now access RedHill’s Talicia® via the PhilRx Platform Phil Inc., a patient… Read More

Delveinsight Business Research LLP The Multiple Sclerosis Market size in the seven major markets was found to be USD 22,381 million in 2020, which is expected to grow by 2032. As per De… Read More

Las Vega (Nevada), United States //— As per DelveInsight’s assessment, globally, Rheumatoid Arthritis pipeline constitutes key companies continuously working towards developing… Read More

 The word "PEGylation" refers to the process of altering biological molecules by covalent conjugation with polyethylene glycol (PEG), a non-toxic, non-immunogenic polymer, in order to c… Read More

The global oral macromolecular formulation market was valued at around US$ 15.7 Mn in 2020, and is expected to exhibit a steady CAGR of around 5.1% over the for… Read More

RedHill Biopharma Ltd. , a specialty biopharmaceutical company, announced preliminary top-line data from the 475-patient global Phase 2/3 study with opaganib (ABC294640)[1] in hospitalized p… Read More

Research Nester published a report titled “Nontuberculous Mycobacterium Treatment Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed over… Read More

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced agreements with Cosmo Pharmaceuticals NV to manufacture two key products; RedHill’s largest selling product in… Read More

Veeva Systems and Bioforum announced their collaboration with RedHill Biopharma Ltd. on a global Phase 2/3 clinical study evaluating opaganib (Yeliva®, ABC294640),1 a first-in-class, ora… Read More

RedHill Biopharma has reported initial findings from a preclinical study, which revealed that its drug candidate, opaganib (Yeliva, ABC294640), could block Covid-19 variants of concern. Opag… Read More

RedHill Biopharma (NASDAQ:RDHL) Price Target & New Coverage by Nomura Nomura revealed to investors and clients in a recent research note that it began coverage on RedHill Biopharma (NA… Read More

Market Highlights: There are wide market for irritable bowel syndrome treatment in the Americas owing to increasing prevalence of patients suffering with anxiety, people feel the effects… Read More

Best and worst stocks of Nasdaq based on performance Today, 2021-01-13 ,best stocks of Nasdaq are: – ArcLight Clean Transition Corp. (symbol: ACTCU, which operates in the Financial Ser… Read More

Recipharm, the contract development and manufacturing organisation , announced ongoing large-scale commercial manufacturing of RedHill Biopharma’s drug, Talicia delayed-release capsule… Read More

Bile Duct Cancer Therapeutics Market Research Report by Leading Key Players - Bayer, AG, Delcath Systems, Senhwa Biosciences, PCI Biotech, ASLAN Pharmaceuticals,RedHill Biopharma and Halozym… Read More

1. Increasing Prevalence of Migraine Expected to Drive the Market Migraine is a neurological disorder that can have incapacitating neurological symptoms. According to the migraine trust… Read More

OverviewA migraine is a headache ailment characterized via recurrent headaches which are moderate to extreme. Normally, the headaches are pulsating in nature, and lasts from two to seventy-t… Read More

Europe Migraine Drug Market was worth USD 1.07 billion in 2016 and estimated to be growing at a CAGR of 4.44 %, to reach USD 1.33 billion by 2021. Migraines are a source of both lost product… Read More